A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2006
10/19/2006	WO2006109823A1 2-thioethenyl carbapenem derivative
10/19/2006	WO2006109642A1 Pharmaceutical composition and method using antifungal agent in combination
10/19/2006	WO2006109323A1 Preparation of [2-methyl-5-phenyl-3-(piperazin-1-ylmethyl)] pyrrole derivatives
10/19/2006	WO2006109317A1 A process for the preparation of poly dl-lactide-co-glycolide nanoparticles having antitubercular drugs encapsulated therein
10/19/2006	WO2006109192A2 Antifungal bifunctional molecules, methods of construction and methods of treating fungal infection therewith
10/19/2006	WO2006109071A2 Vaccine against burkholderia infections
10/19/2006	WO2006108846A1 Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines
10/19/2006	WO2006108828A1 (1, 10b-dihydro-2-(aminoalkyl- phenyl)-5h-pyraz0l0 [1,5-c] [1,3] benz0xazin-5-yl) phenyl methanone derivatives as hiv viral repliation inhibitors
10/19/2006	WO2006108358A1 ANTIVIRAL USE OF ARTIFICIAL CpG-CONTAINING SINGLE-STRANDED OLIGODEOXYNUCLEOTIDES IN COMBINATION WITH RIBAVIRIN
10/19/2006	WO2006108226A1 Vaccine delivery system
10/19/2006	WO2006108215A1 Anti-fungal treatments
10/19/2006	WO2006085212A3 Condensed isoxaline derivatives as inhibitors of phosphodiesterase type-iv
10/19/2006	WO2006079121A3 Methods of treating disease with glycosylated interferon
10/19/2006	WO2006053323B1 Inhibitors of hiv-1 capsid formation: substituted aryl aminomethyl thiazole ureas and analogues thereof
10/19/2006	WO2006050303A3 Intravaginal treatment of vaginal infections with metronidazole compositions
10/19/2006	WO2006046871A3 Peri-operative composition comprising lactobacillus rhamnosus
10/19/2006	WO2006045616A3 β-L-N4-HYDROXYCYTOSINE DEOXYNUCLEOSIDES AND THEIR USE AS PHARMACEUTICAL AGENTS IN THE PROPHYLAXIS OR THERAPY OF VIRAL DISEASES
10/19/2006	WO2005118610A3 Macrocyclic compounds and methods of making and using the same
10/19/2006	US20060235201 Enduring T cell response
10/19/2006	US20060235132 Method of preparing poly(vinyl pivalate) by low temperature suspension-polymerization of vinyl pivalate, and poly(vinyl pivalate) and poly(vinyl alcohol) prepared using same
10/19/2006	US20060235076 Medicinal composition for treating infection with drug-resistant staphylococcus aureus
10/19/2006	US20060235073 Diamino-functional chalcones
10/19/2006	US20060235058 Substituted 5-membered ring compounds and their use
10/19/2006	US20060235054 e.g. 3-substituted 5-(4-fluorophenyl)-4-(4-pyridyl)imidazole-2-thione; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent
10/19/2006	US20060235043 Antiviral Pyrazolopyridine Compounds
10/19/2006	US20060235032 Substituted quinazolines as antiviral agents, especially against cytomegaloviruses
10/19/2006	US20060235027 Inhibitors of cdc25 phosphatases
10/19/2006	US20060234995 Compositions containing piperacillin and tazobactam useful for injection
10/19/2006	US20060234977 Antiviral compostion comprising a sulphated glucose polymer and a bacteriostatic agent
10/19/2006	US20060234955 Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders
10/19/2006	US20060234349 Fungal cell wall synthesis gene
10/19/2006	US20060234342 Human DNA topoisomerase I alpha
10/19/2006	US20060234307 Fusion proteins of of Fc domains with Ang-2 binding peptides; increases biological half life; angiopoietin-2 (Ang-2)
10/19/2006	US20060234283 reporter system reflecting the transport process that transports GPI-anchored proteins to the cell wall was constructed and compounds inhibiting this process were discovered; antifungal agents; inhibiting expression of cell wall glycoproteins and preventing pathogens from showing pathogenicity
10/19/2006	US20060234213 Synthetic peptides useful in biological essays for detecting infections caused by group O HIV-1 viruses
10/19/2006	US20060234208 Novel mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism
10/19/2006	US20060233835 Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
10/19/2006	US20060233833 Novel uses of parapoxvirus preparations
10/19/2006	US20060233830 Vaccines
10/19/2006	US20060233827 85kDa neisserial antigen
10/19/2006	US20060233823 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof
10/19/2006	US20060233822 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof
10/19/2006	US20060233820 Inducing an immune response towards the HPV-16 Papillomavirus native E7 protein, without simultaneously inducing an immunosuppression; cancers associated with an infection
10/19/2006	US20060233816 Use of plant oil-bodies in vaccine delivery systems
10/19/2006	US20060233811 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
10/19/2006	US20060233807 Novel therapies and methods of screening for therapeutic compounds
10/19/2006	US20060233805 Antigen uptake receptor for candida albicans on dendritic cells
10/19/2006	US20060233781 Antimicrobial composition for local use on mucosal membranes and skin
10/19/2006	US20060233746 N-terminally chemically modified protein compositions and methods
10/19/2006	US20060233723 Mouth and/or throat wash
10/19/2006	US20060233719 Delivery of antidepressants through an inhalation route
10/19/2006	DE102005016873A1 New nano-particle useful for production of composition to treatment and/or prophylaxis of proliferative illnesses, cancer and bacterial infections, where nano-particle is bonded therapeutic substance
10/19/2006	CA2604686A1 (1, 10b-dihydro-2-(aminoalkyl- phenyl)-5h-pyraz0l0 [1,5-c] [1,3] benz0xazin-5-yl) phenyl methanone derivatives as hiv viral repliation inhibitors
10/19/2006	CA2604640A1 Methods for treating diseases through interruption of protein maturation, compounds that inhibit the function of molecular chaperones such as protein disulfide isomerases or interfere with glycosylation, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents
10/19/2006	CA2604538A1 Hiv vaccine
10/19/2006	CA2604392A1 Quaternary ammonium halides for treatment of infectious conditions
10/19/2006	CA2604388A1 Preparation of [2-methyl-5-phenyl-3-(piperazin-1-ylmethyl)] pyrrole derivatives
10/19/2006	CA2604330A1 Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines
10/19/2006	CA2604206A1 2-thioethenyl substituted carbapenem derivatives
10/19/2006	CA2603842A1 Rnai therapeutic for respiratory virus infection
10/19/2006	CA2603783A1 Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs
10/19/2006	CA2602391A1 Composition comprising particulate zinc material with a high relative zinc lability
10/19/2006	CA2587848A1 Antiinfective lipopeptides
10/18/2006	EP1712628A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis
10/18/2006	EP1712563A1 Method of isolating monocytes
10/18/2006	EP1712556A1 Azithromycin monohydrate
10/18/2006	EP1712554A1 Pyridobenzoxazine derivative
10/18/2006	EP1712242A1 Method of regulating phosphorylation of sr protein and antiviral agents comprising sr protein activity regulator as the active ingredient
10/18/2006	EP1712239A2 Interleukin-1 inhibitors in the treatment of diseases
10/18/2006	EP1712232A1 Compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
10/18/2006	EP1712231A2 Method for improving the pharmacokinetics of tipranavir
10/18/2006	EP1712229A1 Fluconazole-tinidazole combination for the treatment of vaginal infections, composition thereof and preparation and use of same
10/18/2006	EP1711617A1 Method and compositions for identifying anti-hiv therapeutics compounds
10/18/2006	EP1711531A2 Neutralizing antibodies and methods of use thereof
10/18/2006	EP1711526A2 Treatment of viral infections
10/18/2006	EP1711522A2 Antiviral compositions which inhibit paramyxovirus infection
10/18/2006	EP1711492A1 Substituted quinolines and their use as mycobacterial inhibitors
10/18/2006	EP1711487A1 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
10/18/2006	EP1711486A2 Bis-indole pyrroles useful as antimicrobials agents
10/18/2006	EP1711485A1 Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication
10/18/2006	EP1711481A2 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
10/18/2006	EP1711476A2 Pyrimidyl phosphonate antiviral compounds and methods of use
10/18/2006	EP1711468A1 Process for preparing purified ciprofloxacin
10/18/2006	EP1711182A1 Oral cyclodextrin complexes of antituberculosis drugs
10/18/2006	EP1711178A1 Compositions substantially free of galactomannan containing piperacillin and tazobactam
10/18/2006	EP1711177A1 1H-THIENO 2,3-c PYRAZOLE DERIVATIVES USEFUL AS KINASE I INHIBITORS
10/18/2006	EP1711174A1 Adjuvant compositions
10/18/2006	EP1711161A2 Methods of preventing and treating sars using low ph respiratory tract compositions
10/18/2006	EP1711158A1 Otic detergent composition for animals, with edta and chlorexhidine
10/18/2006	EP1448595B1 Antimicrobial polypeptides from pseudoplectania nigrella
10/18/2006	EP1392686B1 Bicyclic nitrogen-containing heterocyclic derivatives for use as antibacterials
10/18/2006	EP1208196B1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
10/18/2006	EP1183383B1 Siv-based packaging-deficient vectors
10/18/2006	EP1155119B1 Bhv-1 gene-deleted virus vaccine
10/18/2006	EP0969862B1 Synthetic hiv gag genes
10/18/2006	EP0948511B1 Chemical synthesis of nucleosides analogs and their incorporation into polynucleotides
10/18/2006	EP0656788B1 Hla binding peptides and their uses
10/18/2006	CN1849400A Polynucleotides and polypeptides of the erythropoietin gene
10/18/2006	CN1849323A Thienopyrroles as antiviral agents
10/18/2006	CN1849316A 7-(4-substituted 3- cyclopropylaminomethyl-1- pyrrolidinyl) Q uinolonecarboxylic acid derivative

1 ... 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 ... 1798